BASF's Agritech Spinoff Takes Center Stage as Buybacks and Board Reshuffle Reshape the Story
Published on 09/10/2026 at 02:50 | Editorial boerse-global.de
BASF has quietly assembled the pieces for what could be the defining transaction of its corporate overhaul: a mid-2027 listing of its agricultural unit. Deutsche Bank and Goldman Sachs are advising on the flotation of Agricultural Solutions, according to media reports, with the division's total valuation potentially exceeding EUR 20 billion. Shareholders had already cleared the way in late April, voting in favor of carving the crop-science business into a legally separate subsidiary — the formal groundwork for a future trip to the public markets.
The timing matters as much as the mechanics. For investors, the spin-off represents the clearest path to unlocking value trapped inside a conglomerate that has long traded at a discount to more focused rivals. Whether that gap closes depends on how cleanly BASF executes the separation and whether demand for agricultural chemicals cooperates when the listing window opens.
Leadership Overhaul Runs in Parallel
The company's restructuring extends well beyond the balance sheet. Mary Kurian and Livio Tedeschi joined the executive board on May 1, stepping in as Michael Heinz departed on schedule. In August, the supervisory board extended Katja Scharpwinkel's mandate through 2030; she serves as an executive board member, labor director, and head of the Ludwigshafen site. Scharpwinkel had already put her money where her mandate is, purchasing 4,000 BASF shares at EUR 52.79 each back in May — a signal of confidence that fits the narrative management is cultivating: a leaner portfolio paired with continuity at the company's industrial heartland.
That narrative has tangible financial backing. The sale of the coatings division to Carlyle closed over the summer, generating a pre-tax cash inflow of roughly EUR 5.8 billion, while BASF retains a 40% equity stake in the business now operating as Surventis. A share buyback of up to EUR 1 billion, authorized in late July and launched in August, is scheduled to run through the end of April 2027. It forms part of a broader commitment to return EUR 4 billion in capital to shareholders by the end of 2028. During the week of August 24–28 alone, the company repurchased 591,251 of its own shares.
Should investors sell immediately? Or is it worth buying BASF?
Second-Quarter Momentum Underpins the Strategy
These moves rest on a distinctly stronger operating base. Revenue climbed 16% year-on-year to EUR 17.2 billion in the second quarter of 2026, driven by an 11.5% price effect and 7.3% volume growth — a combination that points to restored pricing power. EBITDA before special items reached EUR 2.4 billion, an improvement of EUR 854 million over the prior-year period. The performance prompted BASF to raise its full-year 2026 earnings guidance in early August.
Not everything on the income statement glittered. Special items in second-quarter EBITDA came to minus EUR 484 million, stemming largely from restructuring charges and the rollout of a new ERP system. Those one-off burdens could weigh on net income in coming quarters, particularly if the economic recovery in key markets such as China or Europe loses steam.
Portfolio Surgery Continues on Several Fronts
Beyond agriculture, BASF is divesting its silicate business at the Düsseldorf-Holthausen site to PQ, with completion targeted for the second half of 2026. The company also closed its acquisition of AgBiTech at the end of March, a deal that still needs to prove itself in a volatile agricultural market. Meanwhile, the Durasorb LNG-MAX technology developed by BASF has entered service at a Cheniere Energy facility in Corpus Christi, Texas — a reminder of the group's technological reach in gas processing, even if the segment remains peripheral to the overall earnings picture.
Legal matters continue to simmer in the background. A patent suit against Apple over Face ID technology came to light last Friday, and the shares slipped 1.5% in the wake of that disclosure. Such proceedings consume resources and introduce uncertainty that can weigh on sentiment.
Where the Stock Stands
The market has yet to render a verdict on the flurry of announcements. The shares closed at EUR 52.50 on Wednesday, down 1.7% from the prior week. Even so, the stock is up 18% since the start of the year and sits just 4.6% below its 52-week high of EUR 55.05. It continues to trade above both its 50-day and 200-day moving averages, a configuration that suggests the medium-term uptrend remains intact. The 50-day line at EUR 50.34 marks the nearest support level should sentiment sour.
A busy catalyst calendar lies ahead. BASF will release its third-quarter report on October 28, 2026, hosting an analyst call that should shed light on the pace of IPO preparations for Agricultural Solutions and the status of debt repayments. The company plans to retire bonds and loans with a nominal volume of EUR 1.6 billion ahead of maturity during the current quarter, further trimming its liabilities. Until those fresh figures land, the market appears content to wait — and to watch whether the mid-2027 listing target holds.
Ad
BASF Stock: New Analysis - 10 September
Fresh BASF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
